Ozempic and Wegovy are selected for Medicare's price negotiations
Patients in China will be able to purchase the blockbuster weight-loss drug Wegovy for 1,400 yuan, or about $193, just a fraction of the US list price of $1,349, according to media reports.
Novo Will Limit Wegovy’s China Launch to Avoid Global Disruption
Wegovy Can Keep Weight Off for at Least 4 Years, Research Shows
Wegovy could be covered for at least 3.6M people under new Medicare rules
Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial
The FDA Approves Weight Loss Drug Zepbound, a Wegovy and Ozempic Rival
